Represents the average payment term of customers.

No definition available.

Name:	rmti_AveragePaymentTermOfCustomers
Namespace Prefix:	rmti_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

- Definition

Represents the average payment term of distributors.

+ References

No definition available.

+ Details

Name:	rmti_AveragePaymentTermOfDistributors
Namespace Prefix:	rmti_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

- Definition

Represents the number of distribution and license agreements.

+ References

No definition available.

+ Details

Name:	rmti_NumberOfDistributionAndLicenseAgreements
Namespace Prefix:	rmti_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	duration

- Definition

Product Purchase Agreement, Extension, Binding Forecast Period Due From Counterparty

+ References

No definition available.

+ Details

Name:	rmti_ProductPurchaseAgreementExtensionBindingForecastPeriodDueFromCounterparty
Namespace Prefix:	rmti_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

- Definition

Product Purchase Agreement, One Time Payment From Counterparty

+ References

No definition available.

+ Details

Name:	rmti_ProductPurchaseAgreementOneTimePaymentFromCounterparty
Namespace Prefix:	rmti_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Revenue Recognition [Line Items]

+ References

No definition available.

+ Details

Name:	rmti_RevenueRecognitionLineItems
Namespace Prefix:	rmti_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Definition

For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 42
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-42

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 21
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482907/825-10-50-21

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 20
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482907/825-10-50-20

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 275
-SubTopic 10
-Section 50
-Paragraph 18
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482861/275-10-50-18

Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 275
-SubTopic 10
-Section 50
-Paragraph 20
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482861/275-10-50-20

+ Details

Name:	us-gaap_ConcentrationRiskPercentage1
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:percentItemType
Balance Type:	na
Period Type:	duration

- Definition

Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.

+ References

Reference 1: http://www.xbrl.org/2003/role/exampleRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 49
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482785/280-10-55-49

Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 18
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-18

+ Details

Name:	us-gaap_NumberOfOperatingSegments
Namespace Prefix:	us-gaap_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	duration

- Details

Name:	srt_CounterpartyNameAxis=rmti_DaVitaHealthcarePartnersIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_MajorCustomersAxis=rmti_DaVitaHealthcarePartnersIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Revenue Recognition - Nature of Goods and Services (Details) $ in Millions	1 Months Ended	3 Months Ended			9 Months Ended		12 Months Ended
	Sep. 30, 2024	Sep. 30, 2024	Dec. 31, 2023 USD ($)	Sep. 30, 2023	Sep. 30, 2024 agreement segment	Sep. 30, 2023	Dec. 31, 2023
Revenue Recognition [Line Items]
Number of operating market segments \| segment					1
Customers average payment term					30 days
Distributors average payment term					60 days
Number of distribution and license agreements \| agreement					5
Da Vita Healthcare Partners Inc
Revenue Recognition [Line Items]
Product purchase agreement, one time payment from counterparty \| $			$ 0.4
Product purchase agreement, binding forecast period due from counterparty	12 months
Da Vita Healthcare Partners Inc \| Revenue Benchmark \| Customer Concentration Risk
Revenue Recognition [Line Items]
Customer concentration, percentage		52.00%		50.00%	47.00%	50.00%
Da Vita Healthcare Partners Inc \| Accounts Receivable \| Customer Concentration Risk
Revenue Recognition [Line Items]
Customer concentration, percentage					40.00%		40.00%